Air Treatment Market Overview by Recent Opportunities, Growth

Air treatment market

The Global Air Treatment Report from Global Insight Services is the only authoritative source of information on the air treatment market. The report will provide you with an analysis of the impact of the latest market disruptions such as the Russian-Ukrainian war and Covid-19 on the market. The report provides qualitative analysis of the market using various frameworks such as Porters and PESTLE analysis. The report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. The report also includes a comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, and recent events such as merger and acquisition activities in the market.

Learn more about the air treatment market here: https://www.globalinsightservices.com/reports/air-treatment-market/

Global Air Treatment Market was valued at US$8.3 Billion in 2021 and is projected to reach US$12.2 Billion by 2031, at a CAGR of 3.9% during the period forecast.

The Air Treatment Market is expected to grow at a compound annual growth rate of 8.50% during the forecast period from 2021 to 2028. Data Bridge Market Research report on Air Treatment provides analysis and information regarding the various factors that are expected to prevail throughout the forecast period while providing their impacts on market growth.

To stay “ahead” of your competitors, request a sample – https://www.globalinsightservices.com/request-sample/GIS10478

Key players
BEKO TECHNOLOGIES GMBH (Germany)
Donaldson Company, Inc. (USA)
Friulair Srl (Italy)
Hongrijia Depurate Facility Science&Technology Co., Ltd (China)
Ingersoll Rand Inc. (USA)
KAESER COMPRESSORS (Germany)
Mikropor (Turkey)
Omega Air doo Ljubljana (Slovenia)
Orion Electronics LTD (Hungary)
SPX FLOW, Inc. (USA)

Segmentation of the global air treatment market
By type

Dryers
Industrial filters
Specialized filters
Condensate management
By app

General industry
Food and drink
Pharmaceutical
oil and gas
Chemicals and Petrochemicals
Mining

Get a report customized to your needs –https://www.globalinsightservices.com/request-customization/GIS10478

Market drivers and trends
Growing incidents of chronic health conditions due to air pollution along with rising prospects of industrialization across the globe are the major factors fueling the growth of the market over the projected period. Air pollution is a major cause of morbidity and mortality worldwide. According to the Global Burden of Disease (GBD) study, fine particulate matter (PM2.5) caused 4.2 million deaths and 103.1 million disability-adjusted life years (DALYs). Additionally, in 2019, ambient fine particle pollution was ranked as the fourth leading cause of years of life lost among people in China. Thus, these growing health issues increase the dynamics of the market over the forecast period.

For In-Depth Competitive Analysis, Purchase This Report – https://www.globalinsightservices.com/inquiry-before-buying/GIS10478

With Global Insight Services, you receive:
• 10-year forecasts to help you make strategic decisions
• In-depth segmentation that can be customized to your needs
• Complimentary consultation with lead report analyst
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact us:
Global Insight Services LLC
16192 Coast Road, Lewes DE 19958
Email: [email protected]
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research company
headquartered in Delaware, USA. We are committed to providing our customers
with the highest quality data, analysis and tools to answer all their market research
Needs. With GIS, you can be assured of the quality of the deliverables, the robustness
transparent research methodology and superior service.

This press release was published on openPR.

About Antoine L. Cassell

Check Also

IMU-838 treatment associated with low rate of confirmed disability worsening in relapsing MS

Recently reported interim data from the Phase 2 EMPhASIS trial (NCT03846219) of Immunic’s investigational agent, …